Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

Japanese pharmaceutical company Eisai Co. and U.S. firm Biogen Inc. said Monday that a jointly developed Alzheimer's drug has ...

Biogen BIIB announced that the FDA has approved a monthly maintenance dosing version for its intravenously (IV) administered ...

The U.S. Food and Drug Administration has approved monthly maintenance dosing for Japan's Eisai and partner Biogen's ...

Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab-irmb) has been approved by the US Food and Drug ...

“The problem with the Alzheimer’s group is they were very co-opted,” said Peter J. Whitehouse, MD, PhD, a professor of ...

Turmeric (Curcuma longa), a vibrant yellow spice, a rhizomatous herbaceous plant from the ginger family (Zingiberaceae), has ...

The Brain Tour, inside dementia is an app designed for iOS and Android phones, that uses augmented reality to transport users inside the brain. Whether you're curious to explore a healthy brain or ...

Tokyo: Eisai Co., Ltd. and Biogen Inc. have announced that the U.S. Food and Drug Administration (FDA) has approved the ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.